Scientists Design a Nanoparticle That May Improve mRNA Cancer Vaccines

Scientists Design a Nanoparticle That May Improve mRNA Cancer Vaccines

Johns Hopkins Medicine scientists have developed a nanoparticle — an extremely tiny biodegradable container — that has the potential to improve the delivery of messenger ribonucleic acid (mRNA)-based vaccines. This new nanoparticle delivery system may improve the way vaccines are given for infectious disease, and it may open a new avenue for treating cancer as well. Read more about the study here.

SEE ALL NEWS
Recent Posts
5 Healthy Habits That Help During Cancer Treatment Understanding Mammogram Results A 19-Year Fight Against Prostate Cancer Brings Man to Johns Hopkins Medicine Scientists Advance Efforts to Create ‘Virtual Cell Lab’ As Testing Ground for Future Research with Live Cells Ultra-Processed Foods: Q&A with 2 Dietitians Radiation Therapy Overcomes Immunotherapy Resistance in Some Cancers ‘Power Surges’ on Cancer Cell Membranes May Fuel Progression of Disease New Cancer Target Discovered How surgeons build a new bladder for cancer patients like Deion Sanders